Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Shares Outstanding (2022 - 2025)

Historic Shares Outstanding for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $159.3 million.

  • Prokidney's Shares Outstanding fell 271.94% to $159.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.3 million, marking a year-over-year decrease of 271.94%. This contributed to the annual value of $163.7 million for FY2024, which is 273.57% down from last year.
  • According to the latest figures from Q3 2025, Prokidney's Shares Outstanding is $159.3 million, which was down 271.94% from $159.3 million recorded in Q2 2025.
  • Prokidney's Shares Outstanding's 5-year high stood at $186.5 million during Q1 2022, with a 5-year trough of $159.3 million in Q2 2025.
  • Its 4-year average for Shares Outstanding is $169.7 million, with a median of $168.3 million in 2023.
  • Examining YoY changes over the last 5 years, Prokidney's Shares Outstanding showed a top increase of 153.57% in 2023 and a maximum decrease of 700.01% in 2023.
  • Prokidney's Shares Outstanding (Quarter) stood at $171.6 million in 2022, then decreased by 1.91% to $168.3 million in 2023, then dropped by 2.74% to $163.7 million in 2024, then decreased by 2.69% to $159.3 million in 2025.
  • Its Shares Outstanding was $159.3 million in Q3 2025, compared to $159.3 million in Q2 2025 and $163.2 million in Q1 2025.